We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Zotefoams Plc | LSE:ZTF | London | Ordinary Share | GB0009896605 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 381.00 | 365.00 | 380.00 | 0.00 | 08:00:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics Foam Products | 126.98M | 9.24M | 0.1892 | 20.14 | 186.1M |
TIDMZTF
RNS Number : 9127Z
Zotefoams PLC
26 May 2021
Zotefoams plc
('the Company')
Result of the 2021 Annual General Meeting
26 May 2021 - The 2021 Annual General Meeting of Zotefoams plc was held at the offices of Zotefoams plc, 675 Mitcham Road, Croydon CR9 3AL on 26 May 2021.
Proxy votes were received from shareholders in respect of 30,843,830 ordinary shares amounting to 63.4 % of the issued share capital. The total number of ordinary shares in issue in relation to the AGM is 48,621,234.
All resolutions put to the meeting were passed. Resolutions 1 to 13 inclusive were passed as ordinary resolutions on a show of hands and resolutions 14 to 18 inclusive were passed as special resolutions on a poll. The results of the poll vote and the proxy votes cast in respect of the resolutions received prior to the meeting were as follows:
Resolution For Against Discretion Votes Withheld To receive the Annual Report of the Company for the year ended 31 1. December 2020 30,834,790 0 9,040 250 -------------------------------- ----------- ---------- ----------- --------------- To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2020 set out on pages 70 to 80 of the Annual 2. Report. 30,514,306 320,484 9,040 250 -------------------------------- ----------- ---------- ----------- --------------- To declare a final dividend for the year ended 31 December 2020 of 4.27 pence per ordinary share, such dividend to be payable on 1 June 2021 to shareholders on the register of members of the Company at the close of business on 3. 7 May 2021. 30,834,790 0 9,040 250 -------------------------------- ----------- ---------- ----------- --------------- To re-elect S P Good 4. as a Director. 29,408,438 1,400,352 9,040 26,250 -------------------------------- ----------- ---------- ----------- --------------- To elect D B Stirling 5. as a Director. 30,808,790 0 9,040 26,250 -------------------------------- ----------- ---------- ----------- --------------- T o re-elect G C McGrath 6. as a Director. 30,808,190 600 9,040 26,250 -------------------------------- ----------- ---------- ----------- --------------- T o re-elect J D Carling 7. as a Director. 30,808,790 0 9,040 26,250 -------------------------------- ----------- ---------- ----------- --------------- T o re-elect A M Fielding 8. as a Director. 30,406,794 401,396 9,040 26,850 -------------------------------- ----------- ---------- ----------- --------------- To re-elect D G Robertson 9. as a Director. 30,808,790 0 9,040 26,250 -------------------------------- ----------- ---------- ----------- --------------- To re-elect C A Wall 10. as a Director. 30,808,190 0 9,040 26,850 -------------------------------- ----------- ---------- ----------- --------------- To re-appoint PKF Littlejohn LLP as Auditor of the 11. Company. 30,688,234 556 9,040 146,250 -------------------------------- ----------- ---------- ----------- --------------- To authorise the Audit Committee to determine 12. the Auditor's remuneration. 30,808,234 556 9,040 26,250 -------------------------------- ----------- ---------- ----------- --------------- To authorise the Directors 13. to allot shares. 30,256,568 172,430 382,315 32,767 -------------------------------- ----------- ---------- ----------- --------------- To authorise the Directors to allot equity securities 14. for cash. 30,334,534 120,000 385,315 4,231 -------------------------------- ----------- ---------- ----------- --------------- To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and refinancing) 15. purposes only. 30,335,134 120,000 385,315 3,631 -------------------------------- ----------- ---------- ----------- --------------- To authorise market purchases 16. of shares. 30,451,739 259 385,315 6,767 -------------------------------- ----------- ---------- ----------- --------------- That a general meeting other than an annual general meeting may be called on not less than 17. 14 clear days' notice. 29,945,857 486,058 385,315 26,850 -------------------------------- ----------- ---------- ----------- --------------- That, with effect from the conclusion of the AGM and pursuant to Section 21(1) of the Companies Act 2006, the Articles of Association produced to the meeting, and for the purpose of identification signed by the Chair, be approved and adopted as the Articles of Association of the Company in substitution for, and to the exclusion of, the existing Articles of Association of the 18 Company. 30,312,515 120,000 385,315 26,250 -------------------------------- ----------- ---------- ----------- ---------------
Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2021 Annual General Meeting, which is at the rear of the 2020 Annual Report and which is also available on the Company's website.
Lydia Harratt
Group Company Secretary
Zotefoams plc
020 8664 1600
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce(R) mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).
www.zotefoams.com
AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered trademarks of Zotefoams plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGBBGDUXGDDGBL
(END) Dow Jones Newswires
May 26, 2021 07:08 ET (11:08 GMT)
1 Year Zotefoams Chart |
1 Month Zotefoams Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions